Auvinen P - Search Results

1

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL. Bergamaschi A, et al. Among authors: auvinen p. J Pathol. 2008 Feb;214(3):357-67. doi: 10.1002/path.2278. J Pathol. 2008. PMID: 18044827

2

Expression of hyaluronan in benign and malignant breast lesions.

Auvinen PK, Parkkinen JJ, Johansson RT, Agren UM, Tammi RH, Eskelinen MJ, Kosma VM. Auvinen PK, et al. Int J Cancer. 1997 Oct 21;74(5):477-81. doi: 10.1002/(sici)1097-0215(19971021)74:5<477::aid-ijc1>3.0.co;2-0. Int J Cancer. 1997. PMID: 9355968 Free article.

3

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM. Auvinen P, et al. Am J Pathol. 2000 Feb;156(2):529-36. doi: 10.1016/S0002-9440(10)64757-8. Am J Pathol. 2000. PMID: 10666382 Free PMC article.

4

Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.

Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, LeBaron RG, Raymond WA, Tilley WD, Horsfall DJ. Suwiwat S, et al. Among authors: auvinen p. Clin Cancer Res. 2004 Apr 1;10(7):2491-8. doi: 10.1158/1078-0432.ccr-03-0146. Clin Cancer Res. 2004. PMID: 15073129

5

Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan.

Auvinen P, Tammi R, Tammi M, Johansson R, Kosma VM. Auvinen P, et al. Histopathology. 2005 Oct;47(4):420-8. doi: 10.1111/j.1365-2559.2005.02220.x. Histopathology. 2005. PMID: 16178897

6

Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation.

Karihtala P, Soini Y, Auvinen P, Tammi R, Tammi M, Kosma VM. Karihtala P, et al. Among authors: auvinen p. J Histochem Cytochem. 2007 Dec;55(12):1191-8. doi: 10.1369/jhc.7A7270.2007. Epub 2007 Sep 6. J Histochem Cytochem. 2007. PMID: 17827165

7

Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.

Casalini P, Carcangiu ML, Tammi R, Auvinen P, Kosma VM, Valagussa P, Greco M, Balsari A, Ménard S, Tagliabue E. Casalini P, et al. Among authors: auvinen p. Clin Cancer Res. 2008 Jan 1;14(1):25-31. doi: 10.1158/1078-0432.CCR-07-0450. Clin Cancer Res. 2008. PMID: 18172248

8

Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan.

Tammi RH, Kultti A, Kosma VM, Pirinen R, Auvinen P, Tammi MI. Tammi RH, et al. Among authors: auvinen p. Semin Cancer Biol. 2008 Aug;18(4):288-95. doi: 10.1016/j.semcancer.2008.03.005. Epub 2008 Mar 26. Semin Cancer Biol. 2008. PMID: 18468453 Review.

9

Hyaluronan in human malignancies.

Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Sironen RK, et al. Among authors: auvinen pk. Exp Cell Res. 2011 Feb 15;317(4):383-91. doi: 10.1016/j.yexcr.2010.11.017. Epub 2010 Dec 3. Exp Cell Res. 2011. PMID: 21134368 Review.

10

Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.

Auvinen P, Tammi R, Kosma VM, Sironen R, Soini Y, Mannermaa A, Tumelius R, Uljas E, Tammi M. Auvinen P, et al. Int J Cancer. 2013 Feb 1;132(3):531-9. doi: 10.1002/ijc.27707. Epub 2012 Jul 20. Int J Cancer. 2013. PMID: 22753277 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page